The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FGD1 splice variants as predictors of brain and bone metastatic organotropism in clear cell renal cell carcinoma.
 
Justin Miller
Employment - Merck; Mount Sinai Health System
 
Alyssa Obermayer
No Relationships to Disclose
 
Mitchell Hayes
No Relationships to Disclose
 
Roy Elias
No Relationships to Disclose
 
Nirmish Singla
No Relationships to Disclose
 
Michelle Churchman
No Relationships to Disclose
 
George Grass
Employment - Moffitt Cancer Center and Research Institute
Stock and Other Ownership Interests - Editas Medicine; G1 Therapeutics; GlycoMimetics; Halozyme; Intellia Therapeutics; Lantheus Medical Imaging
Consulting or Advisory Role - MyCareGorithm
Research Funding - Artera
Patents, Royalties, Other Intellectual Property - MODELING VARIABILITY IN RADIOSENSITIVITY AND TUMOR IMMUNE CONTEXTURE TO PERSONALIZE RADIOTHERAPY
 
Ahmad Tarhini
Consulting or Advisory Role - AstraZeneca; Bayer; BioNTech; Bristol-Myers Squibb; Clinigen Group; ConcertAI; Eisai; Genentech/Roche; Instil Bio; Merck; Nested; Novartis; Partner Therapeutics; Sanofi/Regeneron
Research Funding - Acrotech Biopharma (Inst); Agenus (Inst); Agenus (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Genentech/Roche (Inst); InflaRx (Inst); Merck (Inst); OncoSec (Inst); Pfizer (Inst); Sanofi/Regeneron (Inst); Scholar Rock (Inst)
 
Paola Ramos Echevarria
No Relationships to Disclose
 
Alex Soupir
Employment - Moffitt Cancer Center
Stock and Other Ownership Interests - Castle Biosciences
Travel, Accommodations, Expenses - KnowInnovation
 
Youngchul Kim
No Relationships to Disclose
 
Eric Singer
Consulting or Advisory Role - Aura Biosciences
Research Funding - Astellas Medivation
 
Sean Kern
No Relationships to Disclose
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Cardinal Health; Castle Biosciences; Clovis Oncology; Eisai; EMD Serono; Exelixis; Genzyme; Gilead Sciences; Janssen; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Seagen; TTC Oncology
Research Funding - Eisai (Inst); Exelixis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Newlink Genetics
 
Paul Viscuse
No Relationships to Disclose
 
Patrick Hensley
No Relationships to Disclose
 
Timothy Shaw
Patents, Royalties, Other Intellectual Property - TImothy Shaw reports a patent application in CAR T cell therapy US20220267425A1.; Timothy Shaw reports a patent application in CAR T cell therapy US20240216427A1.; Timothy Shaw reports a pending patent application on software for survival analysis.
Travel, Accommodations, Expenses - Aster's Insight; Aster's Insight; Aster's Insight
 
Brandon Manley
Consulting or Advisory Role - Merck; Merck
Patents, Royalties, Other Intellectual Property - EGFR splice variant as a biomarker in renal cancer (Inst)
Expert Testimony - Arnold & Porter